What Satisfai Health does

Dova Health Intelligence (formerly Satisfai Health) is a Vancouver-based medical AI company developing computer-vision and deep-learning software for gastrointestinal disease assessment. The company builds three product lines — DovaVision UC for ulcerative colitis endoscopic severity scoring from colonoscopy videos, DovaVision BE for Barrett's Esophagus surveillance and early esophageal adenocarcinoma detection, and DovaSound for intestinal ultrasound analysis in inflammatory bowel disease — all delivered via a cloud-based API/SaaS platform with three-layered (video/frame/pixel) explainable outputs and embedded quality control. DovaVision BE holds FDA Breakthrough Device Designation (December 2023), and the company is pursuing FDA clearance for DovaVision UC in collaboration with Mayo Clinic. Its proprietary models are trained on 108 million annotated endoscopy frames and validated at 0.867 QWK and 0.869 ICC against expert central reading.

The company earns revenue through subscription-based B2B SaaS contracts for clinical trial imaging analysis, anchored by an exclusive channel partnership with Alimentiv (a GI-specialized CRO) that makes DovaVision UC commercially available on the Notō imaging platform for Phase I-IV ulcerative colitis trials. Additional revenue streams under development include FDA-cleared medical device sales for clinical practice (DovaVision BE, DovaVision UC post-clearance, and DovaSound) and enterprise licensing to pharmaceutical sponsors and academic medical centers. The customer base spans pharmaceutical/biotech trial sponsors (primary), CROs such as Alimentiv (primary), healthcare providers, and academic research institutions including Oxford, Calgary, NYU, Indiana, and UCI. To date the company has disclosed CAD $2 million in non-dilutive grant funding from Canada's DIGITAL Supercluster and acquired Docbot in November 2022; no institutional venture financing has been publicly disclosed.

Name

Satisfai Health

Legal name

Dova Health Intelligence Inc.

Website

https://satisfai.health

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Dova Health Intelligence (formerly Satisfai Health) develops AI-powered computer-vision software for gastrointestinal disease assessment, with DovaVision UC, DovaVision BE, and DovaSound serving pharmaceutical clinical trial sponsors, CROs, and gastroenterology providers through a SaaS/API platform.

Ownership category

akta.pro rank

Product category

Medical Imaging AI Software

NAICS

Software Publishers (513210)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industries

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)

Keywords

• Gastrointestinal AI software
• Endoscopy image analysis
• Medical imaging AI
• Ulcerative colitis diagnostics
• Intestinal ultrasound analysis

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Clinical Trial Services - DovaVision UC: AI-powered endoscopy analysis provided to pharmaceutical companies and CROs for clinical trial endpoints. Currently available for research and clinical trials through Alimentiv partnership. B2B enterprise licensing model.
2. SaaS Platform - API-Based Analysis: Cloud-based SaaS application for video analysis delivered via secure API integration. Subscription-based model for clinical sites, research institutions, and enterprise deployments.
3. Medical Device Development: DovaVision BE and DovaSound in development for clinical practice. Future revenue from FDA-cleared medical devices for hospital and clinical deployment.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Satisfai Health, now operating as Dova Health Intelligence, develops AI-powered computer vision software that analyzes gastrointestinal medical imaging (colonoscopy, gastroscopy, and intestinal ultrasound videos) to deliver quantitative disease severity scoring for ulcerative colitis, Barrett's Esophagus, and inflammatory bowel disease. The products are delivered as cloud-based SaaS with API integration for clinical trials, pharmaceutical research, and future clinical practice.

Product overview

Dova Health Intelligence (formerly Satisfai Health) operates as a unified AI-powered platform with three core products targeting gastrointestinal care and clinical research. The product portfolio centers on DovaVision UC for ulcerative colitis endoscopic analysis, DovaVision BE for Barrett's Esophagus detection, and DovaSound for intestinal ultrasound IBD assessment. All products share a common AI infrastructure built on deep learning models trained on millions of expertly annotated medical images, delivered via secure cloud-based SaaS with embedded quality assurance and API-based integration capabilities. The platform serves both pharmaceutical companies conducting clinical trials and healthcare providers delivering patient care.

Differentiator

Problem solved

Functional benefit

Brands

• DovaVision UC: AI-powered dynamic frame-level Mayo Endoscopic Sub-score feature analysis solution for endoscopy videos in ulcerative colitis clinical trials.
• DovaVision BE
• DovaSound

Products and services

• DovaVision UC AI-powered endoscopy analysis platform providing frame-level quantitative assessments and standardized MES and UCEIS scoring outputs from colonoscopy videos for ulcerative colitis clinical trials and research.
• DovaVision BE AI-powered real-time Barrett's Esophagus surveillance and early esophageal adenocarcinoma detection system with dynamic frame-level detection and granular mapping for dysplastic vs non-dysplastic differentiation. In development with FDA Breakthrough Device Designation.
• DovaSound AI-powered intestinal ultrasound imaging analysis platform for rapid IBD activity assessment in Crohn's disease and ulcerative colitis, with automated detection, segmentation, and standardized IUS measurements aligned with IBUS/IUSCAN standards.

Quantifiable outcome

• 0.867 Quadratic Weighted Kappa (QWK) for video-level MES scoring
• +2 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

13 partnerships are on record, tiered core and strategic.

• Mayo CliniccoreStrategic or Co-development Partner · 7 October 2025Collaboration on development and validation of DovaVision UC MES for Mayo Endoscopic Score. Joint regulatory preparation for FDA clearance. Mayo Clinic provides clinical expertise and validation data.
• AlimentivcoreChannel Partner/ Reseller/ Distributor · 1 May 2025Global GI-focused CRO providing clinical trial imaging services. DovaVision UC commercially available through Alimentiv's Notō platform for Phase I-IV UC clinical trials. Partnership announced at DDW 2025 for AI-powered endoscopy analysis.
• INOVAITstrategicStrategic or Co-development PartnerMoU between DIGITAL and INOVAIT supporting Canadian companies including Dova. Paves way for accelerated commercialization and strengthened innovation pathways.
• SCALE AIstrategicGTM or Marketing PartnerCanada's artificial intelligence cluster that led the Canadian delegation at VivaTech 2026 where Dova was selected as Tech for Change company.
• University of OxfordstrategicStrategic or Co-development PartnerAcademic partnership with Dr. Simon Travis and Dr. James East for AI endoscopy validation. KOLs provide clinical expertise and research collaboration.
• University of CalgarystrategicStrategic or Co-development PartnerAcademic partnership with Dr. Remo Panaccione and Dr. Brian Bressler for IBD research and validation.
• University of AugsburgstrategicStrategic or Co-development PartnerAcademic partnership with Dr. Helmut Messmann for Barrett's Esophagus AI research.
• NYU Grossman School of MedicinestrategicStrategic or Co-development PartnerPartnership with Dr. Mike Dolinger for intestinal ultrasound AI development.
• Western UniversitystrategicStrategic or Co-development PartnerPartnership with Dr. Vipul Jairath, Chief Medical Officer at Alimentiv, for IBD clinical research.
• IBUS (International Bowel Ultrasound)strategicStrategic or Co-development PartnerGlobal KOL organization for bowel ultrasound. Dr. Kerri Novak and Dr. Mike Dolinger as co-founders of iUSCAN.
• IUSCANstrategicStrategic or Co-development PartnerIntestinal Ultrasound Group of the United States and Canada. Partnership for DovaSound IUS AI development.
• Indiana University School of MedicinestrategicStrategic or Co-development PartnerPartnership with Dr. Douglas K. Rex, Distinguished Professor, for GI endoscopy AI validation.
• UCI (University of California Irvine)strategicStrategic or Co-development PartnerPartnership with Dr. Bill Karnes for high-risk colonoscopy and esophageal disorders research.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Medtronic (GI Genius): Medtronic's GI Genius is the most widely deployed AI endoscopy platform, offering real-time polyp detection during colonoscopy. It is the primary incumbent competing with Dova's DovaVision UC for share of AI-augmented endoscopy workflows across hospitals and trials globally.
• Iterative Health: Iterative Health develops AI for gastroenterology, including IBD endoscopic scoring and clinical trial endpoints — directly overlapping DovaVision UC's use case and serving the same pharma-sponsored IBD trial market.

Emerging players

• Virgo Surgical Solutions: Virgo uses AI to automate endoscopic procedure documentation and analysis for IBD and other GI conditions, intersecting Dova's IBD scoring and clinical-trial analytics focus with a complementary workflow angle.
• Cosmo Intelligent Medical Devices: Cosmo develops AI-based GI endoscopy products including the GI Genius lineage and other GI AI tools, positioning it as an emerging competitor in the same AI-endoscopy category as Dova.
• Enlitic: Enlitic develops AI for medical imaging interpretation across modalities. Its broader imaging-AI approach and regulatory experience (where Dova's VP RA/QA previously worked) make it a comparable medical-imaging AI peer.
• Aidence: Aidence develops AI for medical imaging diagnostics (notably lung cancer), comparable to Dova as a specialty-focused medical imaging AI company pursuing clinical adoption and regulatory clearances.
• Arterys: Arterys provides cloud-based AI medical imaging platforms with multiple FDA-cleared products — comparable as a multi-product medical imaging AI SaaS business pursuing specialty clinical workflows similar to Dova's.

Broad incumbents

• Overjet: Overjet is an FDA-cleared dental imaging AI platform expanding across dental specialties. Its AI medical-imaging SaaS model and regulatory footprint (where Dova's VP RA/QA previously worked) make it a broader medical-imaging AI comparable.
• Viz.ai: Viz.ai is an established medical imaging AI company with FDA-cleared products deployed across hospital systems — comparable as a scaled, specialty-focused medical imaging AI SaaS business with regulatory maturity Dova is pursuing.
• Aidoc: Aidoc provides AI-driven radiology imaging analysis deployed across hundreds of hospitals — comparable as a scaled medical imaging AI platform with enterprise SaaS distribution and multi-product FDA clearances.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SatisfaiHealth
• LinkedInlinkedin.com/company/satisfaihealth
• Facebookfacebook.com/satisfaihealth

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Satisfai Health